SMMT vs. MSOS
SMMT (Summit Therapeutics Inc.) is a stock, while MSOS (AdvisorShares Pure US Cannabis ETF) is Small Cap Blend Equities fund actively managed by AdvisorShares. Over the past 5 years, SMMT returned 15.19%/yr vs -35.56%/yr for MSOS. At a 0.14 correlation, their price movements are largely independent.
Performance
SMMT vs. MSOS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SMMT achieves a -12.81% return, which is significantly lower than MSOS's -4.87% return.
SMMT
- 1D
- -1.49%
- 1M
- 8.85%
- 6M
- -22.51%
- YTD
- -12.81%
- 1Y
- -39.00%
- 3Y*
- 94.58%
- 5Y*
- 15.19%
- 10Y*
- 7.37%
MSOS
- 1D
- 0.67%
- 1M
- -10.91%
- 6M
- -5.47%
- YTD
- -4.87%
- 1Y
- 52.20%
- 3Y*
- -10.34%
- 5Y*
- -35.56%
- 10Y*
- —
SMMT vs. MSOS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
SMMT Summit Therapeutics Inc. | -12.81% | -1.99% | 583.72% | -38.59% | 57.99% | -42.77% | 36.23% |
MSOS AdvisorShares Pure US Cannabis ETF | -4.87% | 23.88% | -45.65% | 0.29% | -72.68% | -29.69% | 44.84% |
Correlation
The correlation between SMMT and MSOS is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.13 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.13 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.12 |
Correlation (All Time) Calculated using the full available price history since Sep 2, 2020 | 0.14 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SMMT vs. MSOS — Risk / Return Rank
SMMT
MSOS
SMMT vs. MSOS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Summit Therapeutics Inc. (SMMT) and AdvisorShares Pure US Cannabis ETF (MSOS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SMMT | MSOS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.05 | ||
| Sortino ratioReturn per unit of downside risk | -2.06 | ||
| Omega ratioGain probability vs. loss probability | 0.94 | 1.19 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.74 | 1.04 | -1.78 |
| Martin ratioReturn relative to average drawdown | -1.10 | 1.89 | -2.99 |
Loading charts...
Drawdowns
SMMT vs. MSOS - Drawdown Comparison
The maximum SMMT drawdown since its inception was -95.75%, roughly equal to the maximum MSOS drawdown of -96.25%. Use the drawdown chart below to compare losses from any high point for SMMT and MSOS.
Loading charts...
Drawdown Indicators
| SMMT | MSOS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -95.75% | -96.25% | +0.50% |
Max Drawdown (1Y)Largest decline over 1 year | -55.49% | -52.91% | -2.58% |
Max Drawdown (3Y)Largest decline over 3 years | -64.44% | -81.71% | +17.27% |
Max Drawdown (5Y)Largest decline over 5 years | -91.78% | -94.69% | +2.91% |
Max Drawdown (10Y)Largest decline over 10 years | -95.75% | — | — |
Current DrawdownCurrent decline from peak | -58.45% | -91.82% | +33.37% |
Average DrawdownAverage peak-to-trough decline | -57.64% | -72.03% | +14.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 37.41% | 29.03% | +8.38% |
Volatility
SMMT vs. MSOS - Volatility Comparison
Summit Therapeutics Inc. (SMMT) and AdvisorShares Pure US Cannabis ETF (MSOS) have volatilities of 15.51% and 16.07%, respectively, indicating that both stocks experience similar levels of price fluctuations. This suggests that the risk associated with both stocks, as measured by volatility, is nearly the same. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SMMT | MSOS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 15.51% | 16.07% | -0.56% |
Volatility (6M)Calculated over the trailing 6-month period | 56.74% | 57.17% | -0.43% |
Volatility (1Y)Calculated over the trailing 1-year period | 74.34% | 112.50% | -38.16% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 185.11% | 78.28% | +106.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 144.48% | 73.87% | +70.61% |
Dividends
SMMT vs. MSOS - Dividend Comparison
Neither SMMT nor MSOS has paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|---|
MSOS AdvisorShares Pure US Cannabis ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.27% |
SMMT Summit Therapeutics Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
SMMT and MSOS have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
MSOS has higher volatility (16.07%) compared to SMMT (15.51%). In terms of maximum drawdown, SMMT dropped -95.75% vs MSOS's -96.25%.
MSOS currently has the higher Sharpe Ratio (0.49 vs -0.56), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SMMT and MSOS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer